Biopsy sampling of gastric mucosa at diagnostic endoscopy provides inf
ormation that cannot be obtained by other means. The most common indic
ation for gastric biopsy is the need to know whether or not the patien
t is infected with Helicobacter pylori, and whether the stomach is gas
tritic or not. Microscopic examination of gastric biopsy specimens, in
addition to H. pylori status, provides information about the grade, e
xtent, and topography of gastritis-related and atrophy-related lesions
in the stomach. This information provides further opportunities for a
ssessing the risk and likelihood of various gastric disorders. These a
re: a) The predominance or restriction of the H. pylori-related gastri
tis in the antrum strongly correlates with an increased risk of peptic
ulcer disease, and of duodenal ulcer in particular (the duodenal ulce
r phenotype of gastritis). b) The presence of atrophic gastritis (loss
of normal glands) in the area of the gastric body indicates a low ris
k of ulcer and also a reduction in the capacity of the patient to secr
ete acid. c) The occurrence of advanced atrophic gastritis and intesti
nal metaplasia multifocally in the stomach (advanced multifocal atroph
ic gastritis), and in the lesser curvature and angular notch in partic
ular, are features suggestive of an increased risk of gastric neoplasi
as (the gastric cancer phenotype of gastritis). d) The presence of nor
mal and healthy gastric mucosa indicates, on the other hand, an extrem
ely low risk of both peptic ulcer disease and gastric cancer. In addit
ion to diagnosis of H. pylori-related gastritic lesions, routine gastr
ic biopsies may reveal findings that indicate special forms of gastrit
is, such as eosinophilic, lymphocytic, reactive, or granulomatous gast
ritis (e.g., Crohn's gastritis), or Helicobacter heilmannii gastritis.
These types of gastritis can be found incidentally in a small percent
age of patients who undergo diagnostic gastroscopy for abdominal compl
aints.